Sp1022
THE C.P.R. CURRICULUM — CLINICAL PRACTICE READINESS FOR GASTROENTEROLOGY FELLOWS
Date
May 21, 2024
Presenter
University of Pennsylvania
Tracks
Related Products
SAFETY AND CLINICAL EFFECTIVENESS OF GLP1 AGONISTS IN INFLAMMATORY BOWEL DISEASE PATIENTS
Obesity is prevalent within the inflammatory bowel disease (IBD) population. Several studies suggest that 15%-40% of IBD patients are obese. Obesity has further been associated with higher disease activity and reduced time to flare…
INCIDENCE PROPORTION OF PANCREATIC COMPLICATIONS WITH INCRETIN-BASED THERAPIES: A MULTICENTER POPULATION-BASED STUDY
Background: Transoral outlet reduction endoscopy (TORe) has been shown to be effective in managing weight regain after Roux-en-Y gastric bypass (RYGB), as has the glucagon-like peptide-1 agonist, liraglutide. However, the effect of adjunctive liraglutide after TORe has yet to be assessed…
AGA Enteroendocrine Cells and Incretins: From Basic Science to Blockbuster Drugs
Enteroendocrine cells play a major role in sensing the luminal contents of the gut and communicating with other organs such as the pancreas, liver and brain. The gut-brain connection is essential in the regulation of food intake…
A Multi-Disciplinary Approach to Weight Inclusive Care: From Teaching to Clinical Care
SOCIETY: AGA Optimal nutrition is essential to health and wellness and linked to outcomes of GI and liver diseases. However, gastroenterologists are not equipped with the nutrition knowledge/resources necessary to provide holistic care for patients with digestive diseases…